000			01755 a2200469 4500
005			20250517212116.0
264		0	_c20190212
008			201902s 0 0 eng d
022			_a2405-4569
024	7		_a10.1016/j.euf.2018.04.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aPeyronnet, Benoit
245	0	0	_aLower Urinary Tract Symptoms: What's New in Medical Treatment? _h[electronic resource]
260			_bEuropean urology focus _c01 2018
300			_a17-24 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAcetanilides _xtherapeutic use
650	0	4	_aAdrenergic beta-3 Receptor Agonists _xtherapeutic use
650	0	4	_aAntidiuretic Agents _xtherapeutic use
650	0	4	_aBotulinum Toxins, Type A _xadministration & dosage
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aDeamino Arginine Vasopressin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLower Urinary Tract Symptoms _xdrug therapy
650	0	4	_aMale
650	0	4	_aModels, Animal
650	0	4	_aNocturia _xdrug therapy
650	0	4	_aPhosphodiesterase 5 Inhibitors _xtherapeutic use
650	0	4	_aProspective Studies
650	0	4	_aProstatic Hyperplasia _xdiagnosis
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptors, Vasopressin _xagonists
650	0	4	_aRetrospective Studies
650	0	4	_aThiazoles _xtherapeutic use
650	0	4	_aUrinary Bladder _xdrug effects
650	0	4	_aUrinary Bladder, Overactive _xdrug therapy
700	1		_aBrucker, Benjamin M
700	1		_aMichel, Martin C
773	0		_tEuropean urology focus _gvol. 4 _gno. 1 _gp. 17-24
856	4	0	_uhttps://doi.org/10.1016/j.euf.2018.04.005 _zAvailable from publisher's website
999			_c28297811 _d28297811